ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrated reduction in disease progression, reduced risk ...
NHS pharmacist John Cross ends life after Covid vaccine complications; denied compensation by VDPS after delays of over two ...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...
ATTRv polyneuropathy emerges due to the accumulation of TTR within the PNS, leading to the development of sensory-motor and autonomic neuropathies characterized by length-dependent patterns.
"We've all had our vaccinations. And we continue to since we've lost dad," says John Cross's daughter. "But now you start to ...
OBJECTIVE Polyneuropathy has been reported after gastrectomy performed to treat various lesions. Although thiamine deficiency is a possible cause of this neuropathy, the pathogenesis still remains to ...
Pregnancy largely affects disease activity and clinical course in women with immune-mediated neurological disorders. Chronic inflammatory demyelinating polyneuropathy (CIDP) is rare but the most ...
Orthotopic liver transplantation has become the treatment of choice for familial amyloidotic polyneuropathy. The aims of this study were to evaluate the renal complications post orthotopic liver ...
Riliprubart is under clinical development by Sanofi and currently in Phase III for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). According to GlobalData, Phase III drugs for Chronic ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced ...
Kine Sciences, a clinical-stage, biopharmaceutical company developing small peptides for immune-mediated diseases, announced that the first patient has been dosed in its Phase 1b/2a clinical study of ...